Language: English The consultation of the following contents is free and open. The content of this page corresponds to the latest updated version of the product information leaflet. SIFI S.p.A. guarantees that the information on the safe use of the product contained therein is the most updated. There are no safety notices on this product.
EYESTIL GEL gives relief to the symptoms of ocular dryness. It is intended to soothe symptoms of ocular discomfort due to wearing contact lenses. EYESTIL GEL is also indicated for the medication of wounds and abrasions of the ocular surface caused by traumatic events and after ocular surgery.
EYESTIL GEL contains two natural polymers: sodium hyaluronate and xanthan gum. After instillation in the conjunctival sac, EYESTIL GEL mixes with tears and forms a lubricating, viscous and transparent layer, reducing friction due to eye movements and blinking. EYESTIL GEL alleviates the symptoms of ocular dryness due to environmental and climatic conditions such as pollen, dust, glare, pollution, computer monitor use. EYESTIL GEL also protects the eye surface during wound or abrasion healing processes. The absence of preservative makes the product well tolerated.
Wash/sanitize your hands before use. 1. Make sure that single-dose container is intact. 2. Pull apart the single-dose container from the strip. 3. Hold the single-dose container from the lower part and shake it downwards. 4. Open the unit by twisting and pulling the cap. 5. During instillation of EYESTIL GEL, avoid touching the eye or any surface with the tip of the container.
Do not use EYESTIL GEL if the container is opened or damaged. Avoid touching the eye or any surface with the tip of the opened container. Each single-dose container should only be used immediately after opening. Any residual solution in the vial should not be used since EYESTIL GEL does not contain preservatives and the remaining product may become contaminated, increasing the risk of eye infections. The single-dose containers must be used within 12 weeks after opening of the sachet. Do not use EYESTIL GEL if it is not transparent. Store below 30 °C. Do not use EYESTIL GEL after the expiry date. Do not dispose of the product in the environment after use. For the correct disposal of the product, please follow the national or local regulations. The administration of EYESTIL GEL to children or people with limited skills should be supervised by a responsible adult.
Product interactions with the administration of other ophthalmic drugs are unknown. However, due to the physical properties of the gel, it is advised not to administer other drugs or medical devices for ocular use within 60 minutes after the instillation of EYESTIL GEL. The concomitant use of therapeutic contact lenses after photorefractive keratectomy (PRK) surgery resulted to be compatible with the use of the product. However, the use of other kinds of contact lenses is advised only 60 minutes after the application of EYESTIL GEL.
Any adverse reactions should be reported to the local Vigilance Authorities or to: SIFI S.p.A. – Via Ercole Patti, 36 95025 Aci Sant’Antonio (CT) Italy e-mail: vigilance@sifigroup.com
FOR TOPICAL OCULAR USE ONLY KEEP OUT OF THE SIGHT AND REACH OF CHILDREN
Manufacturer SIFI S.p.A. – Via Ercole Patti, 36 – 95025 Aci S. Antonio (CT) – ITALY
EYESTIL GEL is a sterile medical device.
Last revision of the text: February 2023
PATENT NUMBER: EP 1 358 883
Detailed and updated information on this medical device is available by scanning the QR code that appears in the instructions for use and the carton box with a smartphone. The same information is available at the following https://qr.sifigroup.com/1G809070/
Listen: 
